AUSTIN EPSTEIN: Open Payments
NPI 1245539949 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,180 in 91 payments from 22 companies in 2025. Trend: 2023 $3,151 · 2024 $2,400 · 2025 $2,180
Food & beverage: $2,180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $415 |
| AstraZeneca Pharmaceuticals LP | 15 | $377 |
| Intra-Sana Laboratories | 12 | $327 |
| Novo Nordisk Inc | 7 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Inspire Medical Systems, Inc. | 2 | $104 |
| GlaxoSmithKline, LLC. | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| PFIZER INC. | 3 | $71 |
| Axsome Therapeutics, Inc. | 3 | $64 |
Products named: VRAYLAR, RELTONE 200 MG, BREZTRI, Wegovy, REXULTI, CAPLYTA, INSPIRE, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
